Skip to content

Clinical trials

Phase 2 Gastroesophageal Reflux trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroesophageal Reflux Phase: Phase 2 Country / region: United States Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20053
20062
20072
20082
20094
20101
20124
20133
20141
20161
20171
20181
20201
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated5
Not yet recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Takeda3
Eisai Inc.2
Ironwood Pharmaceuticals, Inc.2
Johns Hopkins University2
XenoPort, Inc.2
Addex Pharma S.A.1
Baylor College of Medicine1
Columbia University1
Edusa Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroesophageal Reflux33
Heartburn6
Asthma2
Barrett Esophagus2
Deglutition Disorders2
Gastroparesis2
Pancreatitis2
Respiratory Insufficiency2
Stroke2
Chronic Cough1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.